Zacks Investment Research lowered shares of Healthcare Realty Trust Incorporated (NYSE:HR) from a hold rating to a sell rating in a research report sent to investors on Tuesday, October 17th.
According to Zacks, “Healthcare Realty Trust is a real estate investment trust that integrates owning, managing and developing income-producing real estate properties associated with the delivery of healthcare services throughout the United States. “
A number of other brokerages have also weighed in on HR. Mizuho restated a neutral rating on shares of Healthcare Realty Trust in a research report on Wednesday, June 28th. BidaskClub lowered Healthcare Realty Trust from a buy rating to a hold rating in a research report on Friday, June 30th. KeyCorp restated a sell rating and set a $25.00 price target on shares of Healthcare Realty Trust in a research report on Thursday, August 24th. Jefferies Group LLC restated a hold rating and set a $36.00 price target on shares of Healthcare Realty Trust in a research report on Monday, July 17th. Finally, Stifel Nicolaus restated a buy rating on shares of Healthcare Realty Trust in a research report on Friday, August 4th. Two analysts have rated the stock with a sell rating, four have given a hold rating and five have issued a buy rating to the stock. The company presently has a consensus rating of Hold and a consensus target price of $33.00.
Healthcare Realty Trust (NYSE HR) traded down 1.21% during trading on Tuesday, reaching $31.80. 719,390 shares of the company traded hands. Healthcare Realty Trust has a 12 month low of $26.66 and a 12 month high of $36.25. The company has a market cap of $3.71 billion, a PE ratio of 30.58 and a beta of 0.31. The company’s 50-day moving average is $32.79 and its 200 day moving average is $33.25.
Healthcare Realty Trust (NYSE:HR) last issued its quarterly earnings data on Wednesday, August 2nd. The real estate investment trust reported $0.39 earnings per share for the quarter, missing the Zacks’ consensus estimate of $0.40 by ($0.01). The business had revenue of $105.20 million during the quarter, compared to the consensus estimate of $105.67 million. Healthcare Realty Trust had a return on equity of 7.38% and a net margin of 28.98%. Healthcare Realty Trust’s quarterly revenue was up 2.5% compared to the same quarter last year. During the same quarter in the prior year, the business posted $0.42 earnings per share. On average, analysts anticipate that Healthcare Realty Trust will post $0.70 earnings per share for the current year.
ILLEGAL ACTIVITY WARNING: “Healthcare Realty Trust Incorporated (NYSE:HR) Downgraded to Sell at Zacks Investment Research” was first posted by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are viewing this piece on another website, it was illegally copied and reposted in violation of US and international copyright & trademark legislation. The correct version of this piece can be accessed at https://www.dispatchtribunal.com/2017/10/27/healthcare-realty-trust-incorporated-hr-downgraded-to-sell-at-zacks-investment-research.html.
In other Healthcare Realty Trust news, Director John Knox Singleton purchased 3,450 shares of the firm’s stock in a transaction dated Tuesday, August 15th. The stock was purchased at an average price of $31.88 per share, for a total transaction of $109,986.00. Following the completion of the purchase, the director now directly owns 17,693 shares of the company’s stock, valued at $564,052.84. The acquisition was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. 1.85% of the stock is owned by insiders.
A number of institutional investors have recently bought and sold shares of the stock. Honeywell International Inc. increased its position in Healthcare Realty Trust by 27.8% during the third quarter. Honeywell International Inc. now owns 62,263 shares of the real estate investment trust’s stock valued at $2,014,000 after acquiring an additional 13,525 shares during the last quarter. Raymond James Financial Services Advisors Inc. increased its position in Healthcare Realty Trust by 15.4% during the third quarter. Raymond James Financial Services Advisors Inc. now owns 12,473 shares of the real estate investment trust’s stock valued at $403,000 after acquiring an additional 1,665 shares during the last quarter. Aperio Group LLC increased its position in Healthcare Realty Trust by 8.9% during the third quarter. Aperio Group LLC now owns 31,266 shares of the real estate investment trust’s stock valued at $1,011,000 after acquiring an additional 2,561 shares during the last quarter. First Trust Advisors LP increased its position in Healthcare Realty Trust by 6.8% during the third quarter. First Trust Advisors LP now owns 36,680 shares of the real estate investment trust’s stock valued at $1,186,000 after acquiring an additional 2,325 shares during the last quarter. Finally, Nationwide Fund Advisors increased its position in Healthcare Realty Trust by 2.9% during the third quarter. Nationwide Fund Advisors now owns 277,336 shares of the real estate investment trust’s stock valued at $8,969,000 after acquiring an additional 7,833 shares during the last quarter. Institutional investors own 91.82% of the company’s stock.
About Healthcare Realty Trust
Healthcare Realty Trust Incorporated is a self-managed and self-administered real estate investment trust. The Company owns, leases, manages, acquires, finances, develops and redevelops real estate properties associated primarily with the delivery of outpatient healthcare services across the United States.
Get a free copy of the Zacks research report on Healthcare Realty Trust (HR)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Healthcare Realty Trust Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthcare Realty Trust Incorporated and related companies with MarketBeat.com's FREE daily email newsletter.